U.S. Congress

381 - 400 of 986 Results

  • HealthBent

    Democrats Disagree About How to Spend Potential Prescription Drug Windfall

    After a year of uncharacteristically being on the same page when it comes to health care, Democratic lawmakers are at loggerheads about what to do next. Most agree the time is ripe to tackle high drug prices. But they divide over whether to take savings from that to move to a Medicare for All insurance system, enhance the current Medicare program or strengthen benefits under the Affordable Care Act.

  • Podcast

    KHNs What the Health?: 100 Days of Health Policy

    Its 100 days into Joe Bidens presidency and a surprisingly large number of health policies have been announced. But health is notably absent from the administrations $1.8 trillion spending plan for American families, making it unclear how much more will get done this year. Meanwhile, the Centers for Disease Control and Prevention loosens its mask-wearing recommendations for those who have been vaccinated, but the new rules are confusing. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHNs Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHNs Julie Appleby, who reported the latest KHN-NPR Bill of the Month episode.

  • KHN & PolitiFact HealthCheck

    A ‘Dose of Hope’? Fact-Checking President Joe Biden’s First Speech to Congress

    In his first speech before a joint session of Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.

  • Podcast

    KHNs What the Health?: Picking Up the Pace of Undoing Trump Policies

    The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Bidens nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • Underfunded And Under Threat

    Public Health Experts Worry About Boom-Bust Cycle of Support

    Congress has poured tens of billions of dollars into public health since last year. While health officials who have juggled bare-bones budgets for years are grateful for the money, they worry it will soon dry up, just as it has after previous crises such as 9/11, SARS and Ebola. Meanwhile, they continue to cope with an exodus from the field amid political pressure and exhaustion that meant 1 in 6 Americans lost their local health department leader.

  • Podcast

    KHNs What the Health?: Planning for Round Two

    The ink is barely dry on the recent covid relief bill, but Democrats in Congress and President Joe Biden are wasting no time gearing up for their next big legislative package. Meanwhile, predictions of more states expanding Medicaid have proved premature. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Kimberly Leonard of Business Insider join KHNs Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHNs Lauren Weber, who reported the latest KHN-NPR Bill of the Month episode.

  • Podcast

    KHNs What the Health?: Getting Down to Work at HHS

    After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.

  • Democrats Eye Medicare Negotiations to Lower Drug Prices

    Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.

  • Podcast

    KHNs What the Health?: ACA Packs More Benefits And More Confusion

    The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHNs Julie Rovner to discuss these issues and more.

  • Podcast

    KHNs What the Health?: Expanding the ACA in an Unpredicted Way

    Beyond the billions of dollars aimed squarely at the pandemic, the covid relief bill cleared by Congress this week includes significant changes to health policy. Among them are the first major expansions to the Affordable Care Act since its enactment 11 years ago and changes that could expand coverage for the Medicaid program. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.